October 2019

On September 25, Discern Health Partner Tom Valuck moderated the expert panel “Strategic Use of Post-Market Real World Evidence (RWE) to Demonstrate Value” during MedTech 2019 in Boston, MA. The panel was composed of health care data analytics and RWE innovation experts from The OCI Group, LLC; Milliman, Inc.; and Archimedic.

The presentation focused on applications of RWE to quality measurement, value-based payment, and coverage and raised issues of interest for the medical device community, such as the potential use of clinical trial and Food and Drug Administration-mandated surveillance data to demonstrate value for payment and coverage.

Download a summary of the panel presentation here.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.